- Home
- CARM vs NTIP Comparison
CARM vs NTIP Comparison
Compare CARM & NTIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CARM
- NTIP
- Stock Information
- Founded
- CARM 2016
- NTIP 1990
- Country
- CARM United States
- NTIP United States
- Employees
- CARM N/A
- NTIP N/A
- Industry
- CARM Biotechnology: Pharmaceutical Preparations
- NTIP Multi-Sector Companies
- Sector
- CARM Health Care
- NTIP Miscellaneous
- Exchange
- CARM Nasdaq
- NTIP Nasdaq
- Market Cap
- CARM 35.5M
- NTIP 29.5M
- IPO Year
- CARM N/A
- NTIP 1998
- Fundamental
- Price
- CARM $0.47
- NTIP $1.29
- Analyst Decision
- CARM Hold
- NTIP
- Analyst Count
- CARM 5
- NTIP 0
- Target Price
- CARM $4.57
- NTIP N/A
- AVG Volume (30 Days)
- CARM 329.1K
- NTIP 19.6K
- Earning Date
- CARM 11-07-2024
- NTIP 10-24-2024
- Dividend Yield
- CARM N/A
- NTIP 7.81%
- EPS Growth
- CARM N/A
- NTIP N/A
- EPS
- CARM N/A
- NTIP N/A
- Revenue
- CARM $20,268,000.00
- NTIP $1,881,000.00
- Revenue This Year
- CARM $46.34
- NTIP N/A
- Revenue Next Year
- CARM N/A
- NTIP N/A
- P/E Ratio
- CARM N/A
- NTIP N/A
- Revenue Growth
- CARM 41.13
- NTIP 129.39
- 52 Week Low
- CARM $0.38
- NTIP $1.24
- 52 Week High
- CARM $3.16
- NTIP $2.25
- Technical
- Relative Strength Index (RSI)
- CARM 21.83
- NTIP 45.22
- Support Level
- CARM $0.38
- NTIP $1.25
- Resistance Level
- CARM $0.82
- NTIP $1.37
- Average True Range (ATR)
- CARM 0.06
- NTIP 0.05
- MACD
- CARM -0.03
- NTIP -0.00
- Stochastic Oscillator
- CARM 18.22
- NTIP 33.33
About CARM Carisma Therapeutics Inc.
CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.
About NTIP Network-1 Technologies Inc.
Network-1 Technologies Inc is involved in the business of the development, licensing, and protection of intellectual property rights. The company's current plan includes continuing to pursue licensing opportunities for its intellectual property assets.